Health
Pioneering diagnostics platform changes the way COVID-19 is detected – News-Medical.Net
Montreal-based Two-Photon Research Inc. announces CAST, a diagnostics platform that changes the way viruses are detected. The CAST platform uses TPR’s patented…
Montreal-based Two-Photon Research Inc. announces CAST, a diagnostics platform that changes the way viruses are detected. The CAST platform uses TPR’s patented Aptamer Molecular Photonic Beacon™ (AMPB) that photonically interfaces with smartphones.
The first application of CAST is for detecting SARS-CoV-2 to help control the COVID-19 pandemic.
During the test, the AMPB binds to the S1 protein of SARS-CoV-2 if it is present in the saliva sample. On binding with the S1 protein, the AMPB responds to…
-
Noosa News20 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News20 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Business20 hours ago2 of the best ASX ETFs to buy for a lifetime of passive income
-
Business21 hours ago16 ASX 200 shares roar to multi-year highs amid new market milestone